knowledge -WSS

knowledge

author：comprehensive 2025-10-01 23:00:16 - browse：6

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： The woman behind the Dana Farber

WSS

Amylyx ALS drug fails large clinical trial

What PEPFAR has meant on the ground in Ukraine

FDA needs staff influx to meet gene therapy needs, Marks says

After sickle

Patients' immediate access to test results puts radiologists in a bind

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

explore

knowledge

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

At least 13 dead in Texas as scorching temps continue

With psoriasis trial ahead, Alumis raises $259 million

ChatGPT in medicine: STAT answers readers' burning questions

FDA approves world's first CRISPR

The cancer drug shortage isn’t new — and neither are the solutions

Air quality improving but still lags in Black, Hispanic communities

Medical leaders decry Supreme Court decision on affirmative action

Pregnancy discrimination could be enabled by AI

Wikipedia

Air quality improving but still lags in Black, Hispanic communities

CMS should re

Pharma patents targeted by Biden in move to slash drug prices

SCOTUS to consider access to abortion pill mifepristone

Just how do doctors, lawmakers, and the public define abortion?

In his State of the Union, Biden takes clear aim at 'Big Pharma'

entertainment

explore

entertainment

focus